mCannabis.RealWorld

The mCannabis.RealWorld Program is the first of its kind, addressing urgent clinical or policy knowledge gaps related to the efficacy and safety of cannabis in a real-world setting. The information gathered from these projects can provide evidence about the health outcomes of diverse patient populations and provide important economic insights to inform clinical or policy decisions.

Applicants can receive up to $300,000 to support approved projects over a maximum term of 24 months. Successful Expression of Interest applicants will be eligible to receive up to an additional $10,000 to support proposal development.

A unique feature of the mCannabis.RealWorld Program is an opportunity to access a panel of leading industry members, academics, clinicians, research facilitators and other health care agents. This panel will support applicants by helping them strengthen their proposals and identify collaborative opportunities.

Applicants who participate in mCannabis.RealWorld can expect the following outcomes:

• Generate real-world evidence to inform clinical or policy decisions.
• Build collaborative connections within the health innovation ecosystem.
• Improve Canadian competitiveness in the global cannabis sector.
• Enable rapid knowledge generation using digital health strategies.
• Create accessible new data sources related to medical cannabis use.
• Enhance patient-centred care.